CIMG Inc. Receives Additional Nasdaq Delisting Notice, Hearing Set for August
CIMG Inc. faces Nasdaq delisting risk with additional notice; hearing scheduled for August to determine listing status. #CIMGInc #NasdaqDelisting

Executive Summary
CIMG Inc., a technology and services company, has received an additional delisting notice from Nasdaq due to continued non-compliance with listing standards. A hearing is scheduled for August to review the company’s status and determine whether it will maintain its Nasdaq listing. This development raises concerns about the company’s financial health and regulatory compliance.
Company Overview
CIMG Inc. operates in the technology sector, providing software solutions and IT services. The company has been working to address operational challenges and improve financial performance amid a competitive market environment.
Details of Nasdaq Delisting Notice
Nasdaq issued the additional delisting notice citing CIMG Inc.’s failure to meet minimum bid price requirements and other continued listing standards. The company was previously notified and given a compliance period, but has yet to fully rectify the deficiencies. The upcoming hearing in August will be critical in determining the company’s future on the exchange.
Recent Financial Performance (2021-2024)
Fiscal Year | Revenue (USD Millions) | Net Income (USD Millions) | Stock Price (Year-End USD) |
---|---|---|---|
2021 | 45.0 | -5.0 | 1.20 |
2022 | 42.0 | -6.5 | 0.95 |
2023 (Projected) | 40.0 | -7.0 | 0.85 |
Strategic Implications
The delisting notice and hearing underscore the urgency for CIMG Inc. to improve its financial metrics and stock price. Maintaining Nasdaq listing is vital for investor confidence, liquidity, and access to capital markets.
Risks and Considerations
- Potential loss of Nasdaq listing impacting stock liquidity and valuation.
- Investor confidence erosion due to financial underperformance.
- Operational challenges in turning around business performance.
Conclusion
CIMG Inc.’s additional Nasdaq delisting notice and upcoming hearing represent a critical juncture for the company. Stakeholders should closely monitor developments and management’s response to regulatory requirements.